Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-03-31 Purchase | 2022-04-04 4:27 pm | Better Therapeutics Inc. | BTTX | Appelbaum Kevin J Kevin Appelbaum or his successor(s) as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020 as amended Chief Executive Officer 10% Owner | 2,500 | $1.9685 | $4,921 | 2,647,969 (Indirect Direct) | View |
| 2021-12-20 Purchase | 2021-12-22 6:03 pm | Better Therapeutics Inc. | BTTX | Appelbaum Kevin J Kevin Appelbaum or his successor(s) as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020 as amended Chief Executive Officer 10% Owner | 1,000 | $4.5999 | $4,600 | 2,410,469 (Indirect Direct) | View |
| 2021-12-15 Purchase | 2021-12-17 8:43 pm | Better Therapeutics Inc. | BTTX | Appelbaum Kevin J Kevin Appelbaum or his successor(s) as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020 as amended Chief Executive Officer 10% Owner | 750 | $4.7065 | $3,530 | 2,409,469 (Indirect Direct) | View |
| 2021-12-10 Purchase | 2021-12-14 5:32 pm | Better Therapeutics Inc. | BTTX | Appelbaum Kevin J Kevin Appelbaum or his successor(s) as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020 as amended Chief Executive Officer 10% Owner | 1,000 | $5.9752 | $5,975 | 2,408,719 (Indirect Direct) | View |
| 2021-12-02 Purchase | 2021-12-06 5:34 pm | Better Therapeutics Inc. | BTTX | Appelbaum Kevin J Kevin Appelbaum or his successor(s) as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020 as amended Chief Executive Officer 10% Owner | 1,000 | $6.633 | $6,633 | 2,407,719 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-04-01 Option Award | 2022-04-04 4:27 pm | N/A 2032-03-31 | Better Therapeutics Inc. | BTTX | Appelbaum Kevin J Kevin Appelbaum or his successor(s) as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020 as amended Chief Executive Officer 10% Owner | 235,000 | $0 | 2,647,969 (Direct) | View |
Ownership | 2021-11-01 8:55 pm | N/A N/A | Better Therapeutics Inc. | BTTX | Appelbaum Kevin J Kevin Appelbaum or his successor(s) as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020 as amended Chief Executive Officer 10% Owner | 0 | $0 | 2,643,600 (Indirect) | View |